$20 Bn
Market Size
$1369 Mn
Import Value
There's growing demand for APIs to fuel local pharma industry in Nigeria, with government support for the industry and increased action from investors.
There's growing demand for APIs to fuel local pharma industry in Nigeria, with government support for the industry and increased action from investors.
$20 Bn
Market Size
$1369 Mn
Import Value
Nigeria's pharmaceutical sector is on the rise, but lags in domestic production of Active Pharmaceutical Ingredients (APIs), the backbone of medicines. Currently, there's 70% import reliance on medicines. This creates a lucrative opportunity for investors in Nigeria's IPR zones.
IPR zones offer investors a springboard into API Pharma manufacturing. Government incentives like tax breaks and infrastructure support, coupled with access to a large market and talent pool, make these zones an attractive proposition. Investors can capitalize on this potential by focusing on niche APIs, cost-effective production methods, or collaborating with research institutions. By overcoming challenges like attracting specialized talent and navigating global competition, investors in IPR zones can become pioneers in bolstering Nigeria's pharmaceutical industry and ensuring better healthcare access for its citizens.
Oct. 8, 2026
Setting Up a Pharmaceutical Manufacturing Business in Kenya: A Practical Guide
View Article
Sept. 9, 2026
Manufacturing and Business Opportunities in Africa: Where Growth Is Taking Shape
View Article
View all media
Africa Business Opportunities: Location-Based 
Africa Business Sectors: Location-Based
Copyright © Arise IIP, 2026
